XML 79 R17.htm IDEA: XBRL DOCUMENT v3.20.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Service Fee Revenue
Our total revenues during the three months ended March 31, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):
 
Three Months Ended
March 31,
2020
 
2019
Commercial insurance
$
155,461

 
$
151,678

Medicare
57,749

 
54,199

Medicaid
6,628

 
7,120

Workers' compensation/personal injury
10,274

 
11,027

Other patient revenue
5,662

 
5,835

Management fee revenue
2,567

 
2,117

Teleradiology and Software revenue
3,770

 
4,386

Other
6,222

 
6,310

Service fee revenue
248,333

 
242,672

Revenue under capitation arrangements
33,231

 
28,877

Total revenue
$
281,564

 
$
271,549
Schedule of goodwill and other intangible assets Activity in goodwill for the three months ended March 31, 2020 is provided below (in thousands):
Balance as of December 31, 2019
$
441,973

Goodwill acquired through the acquisition of Olney Open MRI, LLC
601

Goodwill acquired through the acquisition of MRI at Woodbridge, LLC
1,833

Balance as of March 31, 2020
$
444,407
Effect of derivative instruments on comprehensive income
A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps is as follows (amounts in thousands):
For the three months ended March 31, 2020
Account
 
January 1, 2020 Balance
 
Amount of comprehensive loss recognized on derivative net of taxes
 
March 31, 2020 Balance
 
Location
Accumulated Other Comprehensive Loss, net of taxes
 
$
(5,870
)
 
$
(18,829
)
 
$
(24,699
)
 
Liabilities and Equity

For the twelve months ended December 31, 2019
Account
 
January 1, 2019 Balance
 
Amount of comprehensive loss recognized on derivative net of taxes
 
December 31, 2019 Balance
 
Location
Accumulated Other Comprehensive Loss, net of taxes
 
$
—

 
$
(5,870
)
 
$
(5,870
)
 
Liabilities and Equity

A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):
For the three months ended March 31, 2020
Account
 
January 1, 2020 Balance
 
Amount of comprehensive gain recognized on derivative net of taxes
 
March 31, 2020 Balance
 
Location
Accumulated Other Comprehensive Loss, net of taxes
 
(1,877
)
 
280

 
(1,597
)
 
Liabilities and Equity

For the twelve months ended December 31, 2019
Account
 
January 1, 2019 Balance
 
Amount of comprehensive gain recognized on derivative net of taxes
 
December 31, 2019 Balance
 
Location
Accumulated Other Comprehensive Loss, net of taxes
 
2,506

 
(4,383
)
 
(1,877
)
 
Liabilities and Equity
Schedule of fair value of assets and liabilities
The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):
 
As of March 31, 2020
Level 1
 
Level 2
 
Level 3
 
Total
Current and long term liabilities
 

 
 

 
 

 
 

2016 caps - Interest Rate Contracts
$
—

 
$
727

 
$
—

 
$
727

2019 swaps - Interest Rate Contracts
$
—

 
$
34,937

 
$
—

 
$
34,937


 
As of December 31, 2019
Level 1
 
Level 2
 
Level 3
 
Total
Current and long term liabilities
 

 
 

 
 

 
 

2016 caps - Interest Rate Contracts
$
—

 
$
1,081

 
$
—

 
$
1,081

2019 swaps - Interest Rate Contracts
$
—

 
$
9,477

 
$
—

 
$
9,477


The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):
 
As of March 31, 2020
Level 1
 
Level 2
 
Level 3
 
Total Fair Value
 
Total Face Value
First Lien Term Loans and SunTrust Term Loan
$
—

 
$
595,656

 
$
—

 
$
595,656

 
$
694,875

 
As of December 31, 2019
Level 1
 
Level 2
 
Level 3
 
Total
 
Total Face Value
First Lien Term Loans and SunTrust Term Loan
$
—

 
$
708,948

 
$
—

 
$
708,948

 
$
705,699
Earnings per share Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):
 
Three Months Ended March 31,
2020
 
2019
Net loss attributable to RadNet, Inc.'s common stockholders
$
(16,358
)
 
$
(3,733
)
 
 
 
 
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
 
 
 
Weighted average number of common shares outstanding during the period
50,294,329

 
49,553,694

Basic and diluted net loss per share attributable to RadNet, Inc.'s common stockholders
$
(0.33
)
 
$
(0.08
)
 
 
 
 
Investment in joint ventures
The following table is a summary of our investment in joint ventures during the three months ended March 31, 2020 (in thousands):
Balance as of December 31, 2019
$
34,470

Equity in earnings in these joint ventures
1,955

Balance as of March 31, 2020
$
36,425
Joint venture investment and financial information
The following table is a summary of key balance sheet data for these joint ventures as of March 31, 2020 and December 31, 2019 and income statement data for the three months ended March 31, 2020 and 2019 (in thousands):
Balance Sheet Data:
March 31, 2020
 
December 31, 2019
Current assets
$
28,618

 
$
27,427

Noncurrent assets
69,819

 
61,037

Current liabilities
(9,829
)
 
(9,217
)
Noncurrent liabilities
(23,988
)
 
(18,872
)
Total net assets
$
64,620

 
$
60,375

 
 
 
 
Book value of RadNet joint venture interests
$
29,985

 
$
28,001

Cost in excess of book value of acquired joint venture interests and other
6,440

 
6,469

Total value of Radnet joint venture interests
$
36,425

 
$
34,470

 
 
 
 
Total book value of other joint venture partner interests
$
34,635

 
$
32,374

Income statement data for the three months ended March 31,
2020
 
2019
Net revenue
$
26,341

 
$
27,254

Net income
$
4,245

 
$
3,952